Final Flashcards

(77 cards)

1
Q

____ are H2 receptor antagonists that competitively inhibit H+ secretion by _____ cells

A
  • Tidines ; parietal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

_____ irreversibly bind to proton pump and prevennt acid release

A

PPIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_______ is a prosaglandin analogue that stimulates _____ cell receptors and ______ cell

A

misoprostol; parietal; mucus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

_______ forms a viscous gel network by binding to broken parts of mucus lining

A

sucralfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

______ is an opioid that can help diminish propulsive activity to treat diarrhea

A

loperamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the hypertension subtype _____ is associated with stiffnness of large arteries and adults > 50

A

isolated systolic (SBP only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the hypertension subtype _____ is associated with narrowing or arterioles and adults < 40

A

isolated diastolic (DBP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

______ Hypertension has no known cause wherase _______ hypertension has an identifiable cause

A

primary (essential); secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

(increase or decrease) in angiotensin, aldoseterone, renin is associated with hypertensionn

A

increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

increase aldosterone –> (increase or decrease) of Na+ and H20 –> (increase or decrease in BV

A

increase; increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vasodilator deficiency in hypertension is associated with decreased ______ and _______

A

NO; prostacyclin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Catopril is an example of an _______that blocks angiotensin II production thus ______ secretion. It also prevents inactivation of bradykinin

A

ACE inhibitor; aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Losartan is an an example of an _______ that blocks ______ by blocking the AT1 receptors.

A

ARBs. ; action of angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hydrochlorothiazide is a thiazide-______ diuretic that prevents reabsorption of ___ and ____ in the ____ tubule by inhibiting the co-transporter

A

thiaside-type; Na+ and Cl- ; distal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chlorthalidone and indapamide are thiazide- ______ diuretics that work to decrease ____, _____ and ________

A

thiazide-like, BV, CO, peripheral resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

amlodipine is a ___________ that is most vascular selective and is associated with side effects such as headache, flushing and peripheral edema

A

dihydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

verapamil is a _________ that is most cardiac selective and reduced the calcium influx into cardiac muscle cells.

A

phenulalkylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Dilitazem is a ________ that inhibits voltage gated L-type Ca2+ channels and is associated with bradycardia

A

benzothiazepine`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

G protein coupled receptors for ______ hormones include ____, _____, _____ and are located on the cell surface

A

peptide; Oxytocin, TSH, FSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Receptor Tyrosine Kinases include for _____ hormones include ______ and ______ and are located on the cell surface

A

peptide; insulin receptor, GH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Steroid hormone receptors include … bind to DNA and cause changes in gene expression

A

glucocorticoid, estrogen, thyroid hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the two ways to treat hypersecretion

A
  1. drug that interferes with synthesis or block the receptor
  2. remove/ablate with radiation or surgery 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Short acting bolus insulin is insulin ______ and should be taken 30-60 minutes before meals

A

regular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

fast acting bolus insulin is insulin ______, ________, ______ and should be taken at the start of meals

A

glulisine, lispro, aspart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Intermediate acting basal insulin is insulin _____ and should be taken at bedtime or twice a day
isphane
26
long acting basal insulin is insulin ____, _____ is newer and should be taken once or twice a day because it has no peak effect
glargine, detemir
27
Metformin is an antiglycemic __________ and works by 1. (increase/decrease) _____ gluconeogenesis 2. (increase/decrease) insulin _______ 3. (increase/decrease)______ glucose uptake 4. (increase/decrease) _______ net glucose uptake
biguanide 1. decrease hepatic gluconeogenesis 2. increase insulin sensitivity 3. increase muscle glucose uptake 4. reduce net glucose uptake in intesttine
28
Glyburide is an antidiabetic ________ that works by (increase/decrease) insulin release from beta cells
sulfonylurea; increase
29
Acarbose is an oral antidiabetic _____________ that works by (increase/decrease) the breakdown of starches and carbohydrates at the brush border of the small intestine
alpha-glucosidase inhibitor; decrease
30
Rosiglitazone is an ____________ that is a selective agonist for PPAR and (activates or inhibits) the PPARy receptor to regulate transcription of insulin responsive genes
Thiazolidinedione (TZD); activates
31
Exenatide is an ___________ that binds to GLP-1 on pancreatic beta cells and (increase/decrease) cytosolic calcium --> (increase/decrease) release of insulin-containing granules
incretin mimetic; increase; increase
32
SABA and LABAs act as _______ receptor (agonist ot antagonist)
B2-adrenergic receptor; agonists
33
When _______ bind to receptors on smooth muscle, --> release of ______ ---> removal of _____ via channels ----> ( activation/ inhibition) of myoslin light chain phosphatase ----> uncouple cross bridge = _____
B2-adrenergic receptor agonists --> release of cAMP ---> removal of Ca2+ via channels ----> activation of myosin light chain phosphaase --> uncouple cross bridge = relaxation
34
When _____ binds to the glucocorticoid receptor complex trans-________ prevents translocation of inflammator TF from cytosol --> nucleus and decreases pro-inflammatory cytokines, proteases, ROS trans-_______ up regulates antinflammatory proteins by binding to ______
Corticosterone trans-repression prevents translocation of inflammator TF from cytosol --> nucleus and decreases pro-inflammatory cytokines, proteases, ROS trans-activation up regulates antinflammatory proteins by binding to GRE
35
Classical psychedelics are 5HT 2A receptor _______
partial antagonists
36
______ signalinng is excitatory and Gq coupled and involves the Ca2+ regulation of voltage gated channels in the _____. It also has a role in drug tolerance
Canonical; mPFC
37
______ signalling involves ___ bound receptors for downstream cascades that control cell growth, proliferation and angiogenesis
non-canonical; arrestin
38
Psychedlics work as ______by blocking the action of _____ involved in the termination of _____ action in the synapse and inhibits reuptake from synapses and reverses flow by monoamine transporters ______ (MDMA)
MOA inhibitors; MOA; 5HT; SERT, DAT
39
Ketamine is an glutamate ______ antagonist and activates excitatory_______ signalling
NMDAR; AMPAR
40
MDMA releases ______ and _________ via transporters
serotonin and dopamine
41
the _______ pathway is also known as the dopamine pathway and goes from the ____ --> _____-
mesocorticolimbic ; VTA --> NAcc
42
Mu receptor ________ in the VTA (inhibits/stimulates) GABA release --> dopamine = reward
Antagonism; inhibits
43
respiratory depression occurs as a result of mu receptor _______ in the ________ that interferes with the breathing signal resulting in breathing
antagonism; brainstem
44
Buprenorphine/naloxone has a (High/low) binding affinity to MOR receptors as a _________
high; partial agonist
45
Methadone is a ________ at MOR receptors
full agonist
46
the mesolimbic pathway is associated with _____ symptoms such as delusions, halucinations, disorganized speech and behaviour and catatonic behaviour
positive
47
the mesocortical pathway is associated with _____ symptoms such as Alogia, anhedonia, affective flattenninng, avoilition, asociality
negative
48
the nigrostriatal pathway is asssociated with ______
motor movements
49
the Tuberoinfundibular pathway is associated with ________
prolactin secretion
50
FGA are D2 _________
antagonists
51
SGA are 5HT-2A and D2 ______ and _______ for 5HT-1A which increases dopamine release
antagonists; agonists
52
TGA are D2 _____ and 5HT-2A ________
partial agonists; antagonists
53
5HT-2A_______ and D2 ________ increase prolactin release
agonism; antagonism
54
5HT-2A_______ and D2 ________ decrease prolactin release
antagonism; agonism
55
Risperidone and Paliperidone are examples of _____
SGA
56
Chlorpromazine and Haloperiodl are examples of _____
FGA
57
Aripriprazole and Brexpriprazol are examples of _____
TGA
58
D2 antagonists (FGA and SGA)____-regulate D2 receptors whereas D2 partial agonnists do not
up
59
______ reduces mortality rate
clozapine
60
Clozapine is an _____
SGA
61
Prevalence of disease =
= (# with disease)/ (# with disease + # non-disease) Ex. number eligible for trial / total screened
62
Odds =
= Proportion/ (1- proportion)
63
Proportion =
= Odds/ (1+Odds)
64
Incidence rate is the instantaneous risk for developping a disease at any point in time and =
= number of cases / # years per person of follow up
65
Incidence proportion is the proportion of the population that develops the disease during fixed period of follow up annd =
new cases of disease observed during a defined period of follow up)/ N(aka number at risk during the period)
66
Risk ratio =
= incidence proportion-r / incidence proportion-p = incidence rate -r / incidence rate - p
67
Risk difference =
= incidence proportion-r – incidence proportion - p = incidence rate-r – incidence rate-p
68
Disease odds ratio =
= [ incidence proportion-r/ (1-incidence proportion-r)] \ [incidence proportion-p\ (1-incidence proportion-p)]
69
number needed to treat =
NNT = (1/ |RD|)
70
Clinical research take _____ years and with accelerated approval can be. fastter by ____ years
9 ; 3
71
the median cost to bring a drug to market is ________
1.1 billion
72
The overall likelihood of approval from phase 1 onward is ____ %
8%
73
_____ is the study of rare human diseases with extreme traits. For pain it looks at ____ and ______ targets
extreme genetics; lipid targets, ion channel targets
74
____ mutatin shows extreme genetic pain phenotypes that include ___ functional channels, deficits in channel _____ (easier) and deficits in channel _____ (longer)
SCN9A ; no; opening; inactivation
75
A clinical trial is an expensive experiment to answer the question:__________
does the medicine (safely) work
76
4 reasons for potential clinical trial failure
1. lack of clinical efficacy 2. unmanageable toxicity 3. poor drug-like properties 4. lack of commercial need & poor strategic planning
77
In phase 1 it takes ___ for oncolgy studies ___ for CNS and ___ for ____ to approved In phase 2 it takes ___ years for oncolgy studies ___ years for CNS and ___ years for ____ to be approved
In phase 1 it takes __3_ for oncolgy studies _15__ years for CNS and __33_ for opthamolgy to approved In phase 2 it takes _7__ for oncolgy studies __20_ years for CNS and __34_ for opthamology to approved